Brief: Onesource Specialty Pharma Says Co, Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars
14/07/2026 05:33
BRIEF-Onesource Specialty Pharma Says Co, Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars July 14 (Reuters) - Onesource Specialty Pharma Ltd ONEO.NS:
ONESOURCE SPECIALTY PHARMA - CO, FORMYCON AG ANNOUNCE STRATEGIC MANUFACTURING PARTNERSHIP FOR BIOSIMILARS
ONESOURCE SPECIALTY PHARMA - TO PROVIDE INTEGRATED DS AND DP MANUFACTURING FOR FORMYCON FROM BANGALORE FACILITY
Source text: ID:nBSE32HLv7
Further company coverage: ONEO.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Onesource Specialty Pharma
See all newsIndia's Onesource Specialty Pharma rises most in 2-1/2 months on quarterly profit
Brief: Onesource Specialty Pharma June-Quarter Consol PAT 250 Million Rupees
Brief: Onesource Specialty Pharma Says Co, Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars
Brief: Onesource Specialty Pharma Says Delay In Dr Reddy's Supplies Does Not Materially Impact Co's Operations
Brief: Onesource Specialty Pharma Says USFDA Conducts Routine CGMP Inspection At Onesource SPD Bengaluru